New York State Common Retirement Fund
PEAR

New York State Common Retirement Fund’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History

New York State Common Retirement Fund’s Portfolio PEAR Stock Details PEAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-49,215
Closed -$12.6K – 3494
2023
Q1 		$12.6K Hold
49,215
– – ﹤0.01% 3165
2022
Q4 		$58.1K Buy
49,215
+625
+1% +$1.31K ﹤0.01% 3066
2022
Q3 		$99K Buy
+48,590
New +$82.5K ﹤0.01% 3017

New York State Common Retirement Fund's PEAR Position: Q2 2023 in Review

New York State Common Retirement Fund sold out of Pear Therapeutics, Inc. Class A Common Stock (PEAR) in Q2 2023, closing a stake of 49,215 shares — an estimated $12.6K sold.

New York State Common Retirement Fund first reported a position in PEAR in Q3 2022 and held it in 3 quarters. The position peaked at $99K in Q3 2022. 1 fund tracked by Wall St. Rank holds PEAR as of Q2 2023.

  • New York State Common Retirement Fund reported no remaining Pear Therapeutics, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
  • New York State Common Retirement Fund sold 49,215 Pear Therapeutics, Inc. Class A Common Stock shares in Q2 2023, an estimated $12.6K.
  • New York State Common Retirement Fund first reported a position in Pear Therapeutics, Inc. Class A Common Stock in Q3 2022 and held it in 3 quarters.
  • New York State Common Retirement Fund's Pear Therapeutics, Inc. Class A Common Stock position peaked at $99K in Q3 2022.
  • 1 fund tracked by Wall St. Rank held Pear Therapeutics, Inc. Class A Common Stock as of Q2 2023.

Based on New York State Common Retirement Fund's 13F filing for Q2 2023, filed 7 Aug 2023.